Status:
COMPLETED
Observational Usage and Efficacy Study of Candesartan in Heart Failure Treatment in France
Lead Sponsor:
AstraZeneca
Collaborating Sponsors:
Takeda
Conditions:
Heart Failure
Cohort Study
Eligibility:
All Genders
Brief Summary
The purpose of this study is to describe the way candesartan is used in heart failure treatment in France (treatment initiation and monitoring), treatment stops occurrence and reasons for and patients...
Eligibility Criteria
Inclusion
- outpatients to whom candesartan has been initiated for less than 30 days or during the consultation to treat heart failure
Exclusion
- patients included in a clinical trial the last 30 days before consultation
- patients unable to answer the questions for linguistic or cognitive reasons
- patients who will be difficult to follow during the one year study
Key Trial Info
Start Date :
January 1 2008
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
July 1 2010
Estimated Enrollment :
450 Patients enrolled
Trial Details
Trial ID
NCT00679640
Start Date
January 1 2008
End Date
July 1 2010
Last Update
December 2 2010
Active Locations (103)
Enter a location and click search to find clinical trials sorted by distance.
1
Research Site
Mulhouse, Alsace, France
2
Research Site
Bordeaux, Aquitaine Nord, France
3
Research Site
Dax, Aquitaine Sud, France
4
Research Site
Saint-Jean-de-Luz, Aquitaine Sud, France